This was consistent with the previous study, in which, Oztas [27] et al generated two anti-ZEB2 antibodies, clones 1C6 and 6E5, and assessed their immunoreactivity in a IHC study of cell lines and multiple tumor tissue arrays, yielded the similar results. Here, ZEB2 is linked to neoplasm.